Adaptimmune Snags FDA Nod For TCR Therapy Tecelra
The approval marks the first for an engineered cell therapy for a solid tumor indication, and the company has jumped on commercialization efforts.
The approval marks the first for an engineered cell therapy for a solid tumor indication, and the company has jumped on commercialization efforts.